Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer

EMBO Molecular Medicine · Published 2026-07-30 · DOI 10.1038/s44321-026-00493-7

Free full text

Authors (9)

Zhen Chen, Dongsheng Wang, Songqing Fan, Qiming Wang, Yong Huang, Pan Du, Shidong Jia, Suresh S Ramalingam, Shi-Yong Sun

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chen, Z., Wang, D., Fan, S., et al. (2026). Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer. EMBO Molecular Medicine. https://doi.org/10.1038/s44321-026-00493-7

Related articles